Blar i Institutt for nevromedisin og bevegelsesvitenskap på tidsskrift "Pharmaceutics"
Viser treff 1-1 av 1
-
Application of photodynamic therapy with 5-aminolevulinic acid to extracorporeal photopheresis in the treatment of patients with chronic graft-versus-host disease: A first-in-human study
(Peer reviewed; Journal article, 2021)Extracorporeal photopheresis (ECP), an immunomodulatory therapy for the treatment of chronic graft-versus-host disease (cGvHD), exposes isolated white blood cells to photoactivatable 8-methoxypsoralen (8-MOP) and UVA light ...